NCT02008682View on ClinicalTrials.gov

The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

368

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

liraglutide

Administered subcutaneously (s.c., under the skin) once daily as add-on to the subject's stable pre-trial metformin dose.

DRUG

sitagliptin

Administered orally once daily as add-on to the subject's stable pre-trial metformin dose.

Trial Locations (25)

100071

Novo Nordisk Investigational Site, Beijing

100700

Novo Nordisk Investigational Site, Beijing

100853

Novo Nordisk Investigational Site, Beijing

101200

Novo Nordisk Investigational Site, Beijing

110021

Novo Nordisk Investigational Site, Shenyang

116033

Novo Nordisk Investigational Site, Dalian

130041

Novo Nordisk Investigational Site, Changchun

200080

Novo Nordisk Investigational Site, Shanghai

200092

Novo Nordisk Investigational Site, Shanghai

200120

Novo Nordisk Investigational Site, Shanghai

200240

Novo Nordisk Investigational Site, Shanghai

201199

Novo Nordisk Investigational Site, Shanghai

210011

Novo Nordisk Investigational Site, Nanjing

210012

Novo Nordisk Investigational Site, Nanjing

210029

Novo Nordisk Investigational Site, Nanjing

212001

Novo Nordisk Investigational Site, Zhenjiang

214023

Novo Nordisk Investigational Site, Wuxi

215004

Novo Nordisk Investigational Site, Suzhou

266003

Novo Nordisk Investigational Site, Qingdao

330006

Novo Nordisk Investigational Site, Nanchang

404000

Novo Nordisk Investigational Site, Chongqing

061000

Novo Nordisk Investigational Site, Cangzhou

053000

Novo Nordisk Investigational Site, Hengshui

050000

Novo Nordisk Investigational Site, Shijiazhuang

050051

Novo Nordisk Investigational Site, Shijiazhuang

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY